Asensus Surgical, Inc. (ASXC) stock declined over -4.76% intraday to trade at $0.40 a share on AMEX. The stock opened with a loss of -2.44% at $0.406 and touched an intraday high of $0.415, falling -4.76% against the last close of $0.42. The stock went to a low of $0.39 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue8.23 Million
5Y Sales Change40.20%
Fiscal Year Ends2021-12-30
IndustryHealth Care Equipment
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.
Asensus Surgical, Inc. (AMEX: ASXC) stock price is $0.4 as of the last check on Thursday, June 30. During the trading session, ASXC stock reached the peak price of $0.415 while $0.39 was the lowest point it dropped to.
The AMEX listed ASXC is part of Health Care Equipment industry that operates in the broader Health Care sector. Asensus Surgical, Inc. , a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia.
Mr. Anthony Fernando
Pres, CEO & Director
Mr. Shameze Rampertab B.Sc. MBA, CA, CPA
Exec. VP & CFO
Mr. Joshua B. Weingard
Chief Legal Officer & Sec.
Mr. Paul Ziegler Jr.
VP of Sales
ASXC stock traded closed the last session at $0.398, which is $-0.02 or -4.76% lower than its previous close of $0.42. ASXC's current trading price is 13.74% lower than its 52-week high of $3.23 where as its distance from 52-week low of 0.35% is -87.67%.
Number of ASXC employees currently stands at -. ASXC operates from 1 TW Alexander Drive, Suite 160, Durham, NC 27703, United States.
Official Webiste of $ASXC is: https://www.asensus.com
ASXC stock volume for the day was 1,444,480 shares while in the previous session number of ASXC shares traded was 1,422,640 . The average number of ASXC shares traded daily for last 3 months was 3.08 Million.
The percentage change in ASXC stock occurred in the recent session was -4.76% while the dollar amount for the price change in ASXC stock was $-0.02.
In the recent session, the day high for ASXC stock was $0.415 while the low for ASXC stock touched on the day was $0.39.
The market value of ASXC currently stands at 97.76 Million with its latest stock price at $0.4 and 235.89 Million of its shares outstanding.